MariMed Analyst Ratings
MariMed Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/28/2022 | 60.38% | BTIG | → $0.85 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 10/28/2022 | 60.38% | BTIG | → $0.85 | 開始承保 | →購買 |
MariMed Questions & Answers
MariMed問答
The latest price target for MariMed (OTCQX: MRMD) was reported by BTIG on October 28, 2022. The analyst firm set a price target for $0.85 expecting MRMD to rise to within 12 months (a possible 60.38% upside). 1 analyst firms have reported ratings in the last year.
BTIG於2022年10月28日報道了MariMed(OTCQX：MRMD)的最新目標價。這家分析公司將目標價定為0.85美元，預計MRMD將在12個月內升至(可能上漲60.38%)。1家分析公司在過去一年公佈了評級。
The latest analyst rating for MariMed (OTCQX: MRMD) was provided by BTIG, and MariMed initiated their buy rating.
BTIG提供了對MariMed(OTCQX：MRMD)的最新分析師評級，MariMed啟動了他們的買入評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MariMed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MariMed was filed on October 28, 2022 so you should expect the next rating to be made available sometime around October 28, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閲公開財務報表，與MariMed的高管和客户交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。MariMed的上一次評級是在2022年10月28日提交的，所以你應該預計下一次評級將在2023年10月28日左右提供。
While ratings are subjective and will change, the latest MariMed (MRMD) rating was a initiated with a price target of $0.00 to $0.85. The current price MariMed (MRMD) is trading at is $0.53, which is within the analyst's predicted range.
雖然評級是主觀的，而且會發生變化，但最新的MariMed(MRMD)評級是以0.00美元至0.85美元的目標價啟動的。目前MariMed(MRMD)的交易價格為0.53美元，在分析師的預測範圍內。